Population Screening for Lynch Syndrome with Heather Hampel, MS, LGC

  • [Recording unavailable]

    This talk will explore tumor screening for Lynch syndrome among colorectal and endometrial cancer patients, the utility of this testing both for treatment and genetic diagnosis, and when tumor sequencing can be helpful in the process.

    

Heather Hampel completed her Bachelor of Science degree in Molecular Genetics at the Ohio State University in 1993.   She attained her Master’s degree in Human Genetics from Sarah Lawrence College in 1995.  She received certification from the American Board of Genetic Counseling in 1996.  She worked as a cancer genetic counselor at Memorial Sloan- Kettering Cancer Center before moving to The Ohio State University Comprehensive Cancer Center (OSUCCC) in 1997.

Currently, Heather is a Professor in the Department of Internal Medicine and Associate Director of the Division of Human Genetics.  She is also the Associate Director of Biospecimen Research for the OSUCCC.  She was the study coordinator for the Columbus-area Lynch syndrome study which determined the frequency of Lynch syndrome among newly diagnosed patients with these cancers.  This study culminated in first author publications in the New England Journal of Medicine in May of 2005, Cancer Research in August of 2006, and the Journal of Clinical Oncology in December of 2008.  She is now the PI of the Ohio Colorectal Cancer Prevention Initiative which is screening colorectal cancer patients from 50 hospitals throughout the state for hereditary cancer syndromes. The first major publication from that study showing that 16% of early-onset colorectal cancers are hereditary was published in 2017 in JAMA Oncology. Heather Hampel was the Region IV Representative on the Board of Directors of the Natinoal Society of Genetic Counselors in 2003-4. She was on the Board of Directors for the American Board of Genetic Counseling from 2006-2011, serving as President in 2009 and 2010. She was elected to the Steering Committee member of the National Colorectal Cancer Roundtable in 2016. She has been on the Council of the Collaborative Group of the Americas on Inherited Colorectal Cancer since 2016 and served as President in 2018.

    

Sarah Campian joined Ambry Genetics in 2018 as the Oncology Genetic Specialist for the Great Lakes territory. She previously worked as a clinical genetic counselor at the Grosfeld Cancer Genetics Center at Beaumont Health. Her research interests include Lynch syndrome and identification of gene mutation carriers in minority populations. Sarah received her Bachelors of Science degree in Biology from Saginaw Valley State University. She earned her Masters of Science degree in Genetic Counseling from Wayne State University and is certified by the American Board of Genetic Counseling. 

  • Fri, April 12, 2019
  • 12:00pm PDT
  • Duration: 1 hour
  • C.E.U.
    1 Category 1 Contact Hour
  • P.A.C.E. 1 unit

Webinar Newsletter

Subscribe to receive notifications for future webinars.
Subscribe

Search Results

Start your search...